Table of Contents
The Brown University Psychopharmacology Update · 2007
DOI: 10.1002/pu.20053 ↗Abstract
Abstract Bone Loss and Lower Bone Density Associated with SSRI Use in the Elderly Adjunctive Modafinil May be Effective in Reducing Symptoms of Bipolar Depression Possible Decreased Concentrations of Reboxetine with Anti‐Epileptic Drugs Adverse Cardiac and Bleeding Events with SSRIs SSRIs: A Risk Factor for Bone Loss? Switching to a Generic May Trigger Symptom Relapse Methylphenidate May Affect Developing Brain NIMH Research Targets Faster‐Acting Antidepressants Varenicline May Worsen Schizophrenia Pregabalin (Lyrica) —First Drug to be Approved for Fibromyalgia
EUVIMED